First clinical Immune AG closed for months by court order. (Translated From French)
Image: FLORIAN CELLA
By Emmanuel Borloz
Cancer, AIDS, autism, herpes, depression, psoriasis, chronic fatigue, hepatitis, acne, cirrhosis, osteoporosis, Crohn's disease, Parkinson's or Alzheimer's. Not to many allergies. The list of diseases that a private clinic based in Bussigny assured to process through the injection of a controversial natural product, GcMAF protein (see cons below) , is impressive. A bit too much, even.
For the institution in question, First Immune SA - which takes over the mansion as the medical facility - is closed for several weeks after being raided by police in the background peak. The center is currently at the heart of a vast criminal investigation. As in other European countries.
Vaud earth, the case begins in late 2014, at the CHUV, where five people die in hospital. After investigation and cross-checks, the university hospital, who thinks he has reasons to question the dead, discovers that all five patients have all gone through the private clinic of Bussigny. Reportedly, it is essentially foreign nationals suffering from terminal cancer. Through some 5,000 euros per week, these patients were treated in the clinic and housed in a hotel of West Lausanne.
Medical secrecy lifted
Comforted in the idea that everything is rosy in the establishment that promises bells and whistles on the Internet, the CHUV denounced the case to the central public prosecutor in stride. "We have reported the deaths of patients treated at the University Hospital in Bussigny structure. We did it after discovering a body of consistent evidence that show questionable practices, "says Darcy Christen, spokesman of the CHUV, which will not say more about the nature of these indices.
However, still provides the spokesman, the case is strong because it has convinced the cantonal physician to lift the confidentiality. A prerequisite to deliver the identity of deceased patients to justice. "We found these situations serious enough to try to understand what was happening in Bussigny because clinical First Immune is not officially registered in Switzerland. For us, it therefore does not exist and we were not sure what was happening. In addition, the GcMAF is not allowed in Switzerland, "says Karim Boubaker, cantonal doctor who speaks of" an illegal practice of medicine "and whose services have also gone to court last winter.
It was enough to open a criminal investigation, one of the first steps was a search of the premises in March. There, all the found equipment was seized by police and the few people present - two nurses and two doctors to our knowledge - were taken to the station.
Products under analysis
As for the different products found in local First Immune, they were sent to Swissmedic for analysis. "Operations are underway currently and not prétériter the proceedings, I will make no statement," simply release the Attorney Eric Mermoud.
Always the judicial chapter, respectively advising the President of First Immune group and one of the doctors from the center of Bussigny, MMe Jean-Philippe and Jacques Heim Barillon are little more talkative. "No comment!" Are launching the two lawyers. "The investigation will determine whether patients died from their disease or because of treatments First Immune. This is the most difficult issue of the case ", says his side Karim Boubaker.
Behind the case with international ramifications is a British citizen David Noakes. At the head of the group First Immune, based in Guernsey, the business man without medical training, is soon summoned by the Vaud justice. Contacted midweek, David Noakes is hiding behind the answer also appears to be the rule in this folder: "! No comment" (24 hours)
(Created: 6/19/2015, 5:45 p.m.)
Other surveys in Europe
Belgium has open fires. Fund anticancer medical director of Flatland, Dr. Gauthier Bouche was one of the first to draw the attention of Justice on the activities of First Immune, whose headquarters were in Brussels before being moved to Guernsey. "We have denounced the company to justice because many gray areas surrounding First Immune, his miracle product, its techniques, including the fact that
the famous GcMAF molecule has never been adequately studied in
clinical trials. Its effectiveness is unproven and its marketing is illegal, "says the doctor, the scientific support on which base is First Immune to tout its products are not convincing. Worse, the medical director of anticancer Fund even suspect the Japanese doctor supposed to be the first to discover the anticancer properties of GcMAF to have simply "invented patients and scientific results." And the doctor Mouth ensure that in this crusade against Immune First, it is far from alone: "Shortly after our denunciation, another judicial investigation was opened against the company in England. His bank accounts were curled and his laboratory of Guernsey, where was manufactured the GcMAF, was closed. " In England, the regulatory agency of medicines and health products (MHRA) also puts on guard against First and Immune his miracle treatment. Last February, the government authority enjoined those who have tried the treatment to see their doctor immediately. Fort serious doubts about the quality of the product, which can not boast of successful scientific trials, the agency still provides that "these products can constitute a relevant risk to health."
The protein supposed to cure everything
GcMAF for "Gc Protein derived Macrophage Activating Factor." Behind the barbaric formula hides the protein through which First Immune ensures overcome a long list of diseases. The company ensures that the GcMAF is the best possible remedies to the extent that it is naturally present in the body in healthy people. Every day she would win and the thousands of cancer cells naturally produced by the body and several other disease starts. Conversely, in suffering, certain enzymes prevent the body to produce its own GcMAF, causing the collapse of the immune system. The idea was therefore all First Immune found: GcMAF administer to the sick. To do this, the company has developed an even more powerful molecule, the Goleic, it subsequently patented. "In case of administration of the protein to the patient, attacks against diseases begin again in a few minutes," boasts the First Immune communication, which goes even further. A few more weeks and it would be entirely the effect of the immune system would be restored. On the website of First Immune, remission promises are legion. An example: with the GcMAF, terminally ill cancer patients see their condition improve within the first week, the tumor having already fallen by 25%. Better! After six months, some patients no longer would present no sign of cancer. The whole, still provides First Immune, relies on numerous tests and other scientific articles. Present in England or the Netherlands, First Immune has already treated some 8,000 patients around the world.